Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma
靶向 MMP-2 上游的转录因子 NFE2L2:替莫唑胺耐药胶质母细胞瘤的潜在治疗策略
期刊:Biochemical Pharmacology
影响因子:5.3
doi:10.1016/j.bcp.2019.03.025
Y Rajesh, Angana Biswas, Utkarsh Kumar, Subhayan Das, Indranil Banerjee, Payel Banik, Rashmi Bharti, Santoshi Nayak, Sudip K Ghosh, Mahitosh Mandal